首页> 美国卫生研究院文献>Translational Lung Cancer Research >Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR) lymphocyte to monocyte ratio (LMR) platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)

【2h】

Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR) lymphocyte to monocyte ratio (LMR) platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)

机译：IV期非小细胞肺癌（NSCLC）的预后生物标志物：中性粒细胞与淋巴细胞之比（NLR）淋巴细胞与单核细胞之比（LMR）血小板与淋巴细胞之比（PLR）和晚期肺癌炎症指数（ALI）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Translational Lung Cancer Research
作者
Hiren Mandaliya; Mark Jones; Christopher Oldmeadow; Ina IC Nordman;
展开▼
作者单位

展开▼
年(卷),期 2019(8),6
年度 2019
页码 -1
总页数 9
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Prognostic; biomarker; lung cancer;

机译：预后;生物标志物;肺癌;

相似文献

外文文献
中文文献
专利

1. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab [J] . Diem Stefan, Schmid Sabine, Krapf Mirjam, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2017,第期

机译：中性粒细胞到淋巴细胞比（NLR）和血小板到淋巴细胞比（PLR）作为用Nivolumab处理的非小细胞肺癌（NSCLC）患者的预后标志物
2. Use of the neutrophil to lymphocyte ratio (NLR) and the platelet to lymphocyte ratio (PLR) for prognostication of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT): a systematic review [J] . Daegan Sit, Thomas Raissi, Meredith Giuliani, Journal of radiation oncology . 2019,第1期

机译：使用中性粒细胞与淋巴细胞比率（NLR）和血小板到淋巴细胞比（PLR）用于患有立体定向体放射治疗（SBRT）治疗的早期非小细胞肺癌（NSCLC）的预后（SBRT）：系统审查
3. Prognostic Value of Changes in Neutrophil-To-Lymphocyte Ratio (NLR), Platelet-To-Lymphocyte Ratio (PLR) and Lymphocyte-To-Monocyte Ratio (LMR) for Patients with Cervical Cancer Undergoing Definitive Chemoradiotherapy (dCRT) [J] . Hyder J., Jang H., Kim S., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：中性粒细胞对淋巴细胞比（NLR），血小板对淋巴细胞比（PLR）和淋巴细胞对单核细胞比（LMR）的预后值宫颈癌患者进行了明确的化学疗法（DCRT）
4. Phenotyping Tumor Inltrating Lymphocytes (PhenoTIL) on HE Tissue Images: Predicting Recurrence in Lung Cancer [C] . Cristian Barrera, German Corredor, Xiangxue Wang, Society of Photo-Optical Instrumentation Engineers;SPIE Medical Imaging Conference . 2019

机译：H＆E组织图像上的肿瘤浸润淋巴细胞（PhenoTIL）的表型：预测肺癌的复发。
5. ARYL HYDROCARBON HYDROXYLASE INDUCTION IN HUMAN LUNG TISSUE, PULMONARY MACROPHAGES, AND BLOOD LYMPHOCYTES: EFFECTS OF CIGARETTE SMOKING AND LUNG CANCER [D] . MCLEMORE, THEODORE L. -1

机译：人肺组织，肺巨噬细胞和血液淋巴细胞中的芳烃羟化酶诱导：香烟烟雾和肺癌的影响
6. Preoperative peripheral blood neutrophil-to-lymphocyte ratios (NLR) and platelet-to-lymphocyte ratio (PLR) related nomograms predict the survival of patients with limited-stage small-cell lung cancer [O] . Chunji Chen, Haitang Yang, Deng Cai, 2021

机译：术前外周血中性粒细胞到淋巴细胞比率（NLR）和血小板到淋巴细胞比（PLR）相关的墨顶图预测有限阶段小细胞肺癌患者的存活率
7. 176P Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) [O] . M. Vitorino, T. Tomas, S. Almeida, 2021

机译：176p中性粒细胞到淋巴细胞比（NLR）和血小板到淋巴细胞比（PLR）作为非小细胞肺癌患者的预后标志物（NSCLC）

Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR) lymphocyte to monocyte ratio (LMR) platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)

著录项

相似文献

相关主题

期刊订阅